Literature DB >> 12053087

Growth failure in early life: an important manifestation of Turner syndrome.

Michael L Davenport1, Natavut Punyasavatsut, Paul W Stewart, Daniel F Gunther, Lars Sävendahl, Virginia P Sybert.   

Abstract

The goals of this study were to test the hypothesis that girls with Turner syndrome (TS) experience growth failure early in life and to establish model-based normative growth charts for 0- to 8-year-old American girls with TS. Full-term girls with TS who had 5 or more measurements of height obtained during their first 10 years of life prior to initiation of growth hormone, estrogen and/or androgen therapy were eligible for this study. A nonlinear mixed-effects model comprising the first two components of the infancy-childhood-puberty (ICP) model of growth was fitted to the longitudinal height measurements and compared with those of healthy American girls. Height measurements (n = 1,146) from 112 girls with TS (45,X: 57.1%; 45,X/46,XX: 12.5%; 46,X, iso(X): 4.5%, and other: 25.9%) were analyzed. Mean height SDS fell from -0.68 at birth to -1.60 at 1 year, -1.80 at 2 years and -1.95 at 3 years. When compared to controls (676 girls, 4,537 measurements), girls with TS grew more slowly due to three principal factors: a slow growth rate of the infancy component, a slow growth rate at the onset of the childhood component, and delayed onset of the childhood component. Traditional concepts of growth failure in TS should be revised. Physicians should consider the diagnosis of TS in any girl with unexplained failure to thrive or short stature, even in the first 3 years of life. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12053087     DOI: 10.1159/000058376

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  14 in total

1.  Analysis of short stature cases referred for genetic evaluation.

Authors:  Anupriya Kaur; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2012-03-24       Impact factor: 1.967

2.  Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone.

Authors:  Jovana Juloski; Branislav Glisic; Ivana Scepan; Jelena Milasin; Katarina Mitrovic; Marko Babic
Journal:  Clin Oral Investig       Date:  2012-09-23       Impact factor: 3.573

3.  Response to three years of growth hormone therapy in girls with Turner syndrome.

Authors:  Hong Kyu Park; Hae Sang Lee; Jung Hee Ko; Il Tae Hwang; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-03-31

4.  Growth hormone plus childhood low-dose estrogen in Turner's syndrome.

Authors:  Judith L Ross; Charmian A Quigley; Dachuang Cao; Penelope Feuillan; Karen Kowal; John J Chipman; Gordon B Cutler
Journal:  N Engl J Med       Date:  2011-03-31       Impact factor: 91.245

5.  A highly sensitive, high-throughput assay for the detection of Turner syndrome.

Authors:  Scott A Rivkees; Karl Hager; Seiyu Hosono; Anastasia Wise; Peining Li; Henry M Rinder; Jeffrey R Gruen
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

6.  Growth status of children in well-baby outpatient clinics and related factors.

Authors:  Sercan Bulut Çelik; Figen Şahin; Ufuk Beyazova; Hüseyin Can
Journal:  Turk Pediatri Ars       Date:  2014-06-01

7.  Growth Hormone Treatment in Turner's Syndrome: A Real World Experience.

Authors:  Vijay Sheker Reddy Danda; P Sreedevi; G Arun; P Srinivas Rao
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

8.  The diagnostic work up of growth failure in secondary health care; an evaluation of consensus guidelines.

Authors:  Floor K Grote; Wilma Oostdijk; Sabine Mpf De Muinck Keizer-Schrama; Paula van Dommelen; Stef van Buuren; Friedo W Dekker; Arnoldus G Ketel; Henriette A Moll; Jan M Wit
Journal:  BMC Pediatr       Date:  2008-05-13       Impact factor: 2.125

9.  Growth curves for girls with Turner syndrome.

Authors:  Fabio Bertapelli; Antonio de Azevedo Barros-Filho; Maria Ângela Reis de Góes Monteiro Antonio; Camila Justino de Oliveira Barbeta; Sofia Helena Valente de Lemos-Marini; Gil Guerra-Junior
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

10.  Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies.

Authors:  Antonia A Dominguez; H Rosaria Chiang; Meena Sukhwani; Kyle E Orwig; Renee A Reijo Pera
Journal:  Sci Rep       Date:  2014-09-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.